Article
Ex vivo and in vivo biological behavior of Leishmania (Viannia) shawi
São Paulo University Medical School Department of Pathology Av. Dr. Arnaldo, 455 01246-903 São Paulo SP Brazil
Parasitology Research (impact factor:
2.15).
04/2012;
105(6):1741-1747.
DOI:10.1007/s00436-009-1614-7
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Proteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation.
[show abstract] [hide abstract]
ABSTRACT: Leishmania (Viannia) shawi parasite was first characterized in 1989. Recently the protective effects of soluble leishmanial antigen (SLA) from L. (V.) shawi promastigotes were demonstrated using BALB/c mice, the susceptibility model for this parasite. In order to identify protective fractions, SLA was fractionated by reverse phase HPLC and five antigenic fractions were obtained. F1 fraction was purified from L. (V.) shawi parasite extract by reverse phase HPLC. BALB/c mice were immunized once a week for two consecutive weeks by subcutaneous routes in the rump, using 25 μg of F1. After 1 and 16 weeks of last immunization, groups were challenged in the footpad with L. (V.) shawi promastigotes. After 2 months, those same mice were sacrificed and parasite burden, cellular and humoral immune responses were evaluated. The F1 fraction induced a high degree of protection associated with an increase in IFN-γ, a decrease in IL-4, increased cell proliferation and activation of CD8+T lymphocytes. Long-term protection was acquired in F1-immunized mice, associated with increased CD4+ central memory T lymphocytes and activation of both CD4+ and CD8+ T cells. In addition, F1-immunized groups showed an increase in IgG2a levels. The inductor capability of antigens to generate memory lymphocytes that can proliferate and secrete beneficial cytokines upon infection could be an important factor in the development of vaccine candidates against American Tegumentary Leishmaniasis.Parasites & Vectors 03/2012; 5:64. · 2.94 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
BALB/c mice
classical behavior
draining lymph nodes
ex vivo behavior
Ex vivo experiments
first description
germinative centers
higher infection index
higher lesion size
histological changes
histopathological changes
humoral immune responses
infection index
murine model
nitric oxide
parasites
Peritoneal macrophages
skin inoculation site
stationary phase
vivo experiments